BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15199358)

  • 1. Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting.
    Gomma AH; Hirschfield GM; Gallimore JR; Lowe GD; Pepys MB; Fox KM
    Am Heart J; 2004 Jun; 147(6):1071-7. PubMed ID: 15199358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.
    Segev A; Kassam S; Buller CE; Lau HK; Sparkes JD; Connelly PW; Seidelin PH; Natarajan MK; Cohen EA; Strauss BH
    Eur Heart J; 2004 Jun; 25(12):1029-35. PubMed ID: 15191773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
    Dibra A; Mehilli J; Braun S; Hadamitzky M; Baum H; Dirschinger J; Schühlen H; Schömig A; Kastrati A
    Am Heart J; 2005 Aug; 150(2):344-50. PubMed ID: 16086941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis.
    Caixeta AM; Brito FS; Costa MA; Serrano CV; Petriz JL; Da Luz PL
    Catheter Cardiovasc Interv; 2007 Mar; 69(4):500-7. PubMed ID: 17285569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation.
    Karaca I; Aydin K; Yavuzkir M; Ilkay E; Akbulut M; Isik A; Arslan N
    J Int Med Res; 2005; 33(4):389-96. PubMed ID: 16104442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elective stenting in small coronary arteries: results of the Italian prospective multicenter registry MICROSCOPE.
    Airoldi F; Di Mario C; Presbitero P; Maiello L; Carcagnì A; Bortone A; Cremonesi A; Castriota F; Frasheri A; Rubino A; Pernice V; Rubartelli P; Reimers B; Colombo A
    Ital Heart J; 2002 Jul; 3(7):406-11. PubMed ID: 12189969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting.
    Zurakowski A; Wojakowski W; Dzielski T; Milewski K; Gościńska-Bis K; Tendera M; Buszman P
    Kardiol Pol; 2009 Jun; 67(6):623-30. PubMed ID: 19618318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microsatellite polymorphism of heme oxygenase-1 is associated with baseline plasma IL-6 level but not with restenosis after coronary in-stenting.
    Li P; Elrayess MA; Gomma AH; Palmen J; Hawe E; Fox KM; Humphries SE
    Chin Med J (Engl); 2005 Sep; 118(18):1525-32. PubMed ID: 16232329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation.
    Park DW; Lee CW; Yun SC; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Heart; 2007 Sep; 93(9):1087-92. PubMed ID: 17309906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic markers of persistent Chlamydia pneumonia infection and long-term prognosis after successful coronary stenting.
    Zairis MN; Papadaki OA; Psarogianni PK; Thoma MA; Andrikopoulos GK; Batika PC; Poulopoulou CG; Trifinopoulou KG; Olympios CD; Foussas SG
    Am Heart J; 2003 Dec; 146(6):1082-9. PubMed ID: 14661003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma C-reactive protein level predicts rapid progression of non-target atherosclerotic lesions in patients with stable angina after stenting.
    Xu YL; Li JJ; Xu B; Zhu CG; Yang YJ; Chen JL; Qiao SB; Yuan JQ; Qin XW; Ma WH; Yao M; Liu HB; Wu YJ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2011 Oct; 124(19):3022-9. PubMed ID: 22040548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement.
    Rittersma SZ; de Winter RJ; Koch KT; Schotborgh CE; Bax M; Heyde GS; van Straalen JP; Mulder KJ; Tijssen JG; Sanders GT; Piek JJ
    Clin Chem; 2004 Sep; 50(9):1589-96. PubMed ID: 15205368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined periprocedural evaluation of CRP and TNF-alpha enhances the prediction of clinical restenosis and major adverse cardiac events in patients undergoing percutaneous coronary interventions.
    Kubica J; Kozinski M; Krzewina-Kowalska A; Zbikowska-Gotz M; Dymek G; Sukiennik A; Piasecki R; Bogdan M; Grzesk G; Chojnicki M; Dziedziczko A; Sypniewska G
    Int J Mol Med; 2005 Jul; 16(1):173-80. PubMed ID: 15942695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions.
    Moses JW; Weisz G; Mishkel G; Caputo R; O'shaughnessey C; Wong SC; Fischell TA; Mooney M; Williams DO; Popma JJ; Fitzgerald P; Smith S; Kuntz RE; Collins M; Cohen SA; Leon MB
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):505-12. PubMed ID: 17896408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stenting alone versus debulking and debulking plus stent in branch ostial lesions of native coronary arteries.
    Chung CM; Nakamura S; Tanaka K; Tanigawa J; Kitano K; Akiyama T; Matoba Y; Katoh O
    Heart Vessels; 2004 Sep; 19(5):213-20. PubMed ID: 15372295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of short term (3 weeks) testosterone treatment on serum inflammatory markers in men undergoing coronary artery stenting.
    Guler N; Batyraliev T; Dulger H; Ozkara C; Tuncer M; Aslan S; Okut H; Agirbasli M
    Int J Cardiol; 2006 May; 109(3):339-43. PubMed ID: 16040142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting.
    Kozinski M; Kubica J; Sukiennik A; Zbikowska-Gotz M; Krzewina-Kowalska A; Radomski M; Rychter M; Bialoszynski T; Jablonski M; Demidowicz K; Grzesk G; Bogdan M; Chojnicki M; Grabczewska S; Dziedziczko A
    Int J Mol Med; 2007 Jan; 19(1):187-95. PubMed ID: 17143564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does a carbon ion-implanted surface reduce the restenosis rate of coronary stents?
    Jung JH; Min PK; Kim JY; Park S; Choi EY; Ko YG; Choi D; Jang Y; Shim WH; Cho SY
    Cardiology; 2005; 104(2):72-5. PubMed ID: 16020923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of C-reactive protein on in-stent restenosis: a meta-analysis.
    Li JJ; Ren Y; Chen KJ; Yeung AC; Xu B; Ruan XM; Yang YJ; Chen JL; Gao RL
    Tex Heart Inst J; 2010; 37(1):49-57. PubMed ID: 20200627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.